Omega-3s (EPA and DHA) reduce inflammation and support heart and brain — but most people buy the wrong form or oxidized oil; the form (triglyceride vs ethyl ester) and freshness matter as much as the dose.
Omega-3 fatty acids are one of the most researched supplements in existence — and also one of the most misunderstood. Most people either take too little, buy the wrong form, or don't know whether they need more EPA or DHA for their goal. This guide covers all of it: the clinical evidence on cardiovascular protection and mood, the biochemistry behind EPA vs DHA, why the form of fish oil you buy matters more than the brand, and the oxidation problem that turns cheap fish oil from anti-inflammatory to pro-inflammatory.
Omega-3 fatty acids are long-chain polyunsaturated fats. The three main dietary forms are ALA (alpha-linolenic acid, from plants), EPA (eicosapentaenoic acid), and DHA (docosahexaenoic acid). ALA is found in flaxseed, chia, and walnuts — but human conversion of ALA to EPA is roughly 5–10%, and to DHA less than 0.5%. For practical purposes, plant-based ALA does not raise your EPA or DHA levels meaningfully. You need preformed EPA and DHA from marine sources or algae.
EPA and DHA are not interchangeable. They have distinct biochemical roles, and the ratio between them determines which health outcomes you're most likely to influence.
EPA is the precursor to a family of signaling molecules called eicosanoids — specifically the Series-3 prostaglandins and thromboxanes, which are anti-inflammatory, and resolvins (Resolvin E1, E2, E3), which actively resolve existing inflammation rather than just suppressing it. This makes EPA particularly important for acute and chronic inflammatory conditions — joint pain, autoimmune disease, inflammatory bowel disease, and cardiovascular disease (which is largely driven by arterial inflammation).
EPA also has the strongest evidence for mood regulation and depression. A landmark 2019 meta-analysis by Liao et al. analyzed 26 RCTs and found that EPA-dominant formulations (with >60% of total omega-3 as EPA) produced significant antidepressant effects, while DHA-dominant or mixed formulations did not. The effect size was comparable to low-dose antidepressants in mild-to-moderate depression. The proposed mechanism involves EPA's effect on neuroinflammation — depression is increasingly understood as an inflammatory disorder in a significant subset of patients.
DHA is the predominant structural fatty acid in the brain (comprising roughly 10–20% of total brain fatty acids) and the retina (where it makes up 50–70% of photoreceptor membrane phospholipids). It does not function primarily as a signaling molecule — its role is structural and architectural. DHA-rich membranes are more fluid and flexible, which affects everything from synaptic signaling speed to protein receptor function.
This structural role makes DHA uniquely critical during fetal brain development and early childhood. Maternal DHA status during pregnancy directly influences infant neurodevelopmental outcomes — visual acuity, cognitive development, and language acquisition. DHA accumulates rapidly in the fetal brain during the third trimester. For pregnant and breastfeeding women, DHA is not optional.
DHA is also the key nutrient in the AREDS2 trial data on age-related macular degeneration (AMD). The retinal photoreceptors depend on DHA-rich membranes for function, and deficiency accelerates photoreceptor degeneration in AMD progression.
| Property | EPA | DHA |
|---|---|---|
| Primary role | Signaling, anti-inflammatory | Structural (brain, retina) |
| Key metabolites | Resolvins E, prostaglandins Series-3 | Neuroprotectins, maresins |
| Best evidence for | Depression, CV disease, inflammation | Brain development, AMD, pregnancy |
| Typical ratio in fish oil | ~55–60% of combined EPA+DHA | ~40–45% of combined EPA+DHA |
| Who needs more | Depression, autoimmune, high CRP | Pregnant women, children, AMD risk |
REDUCE-IT (Reduction of Cardiovascular Events with Icosapentaenoic Acid–Intervention Trial) tested Vascepa — a pharmaceutical-grade pure EPA product (icosapentaenoic acid) — at 4g/day in patients with elevated triglycerides who were already on statins. After a median follow-up of 4.9 years, the EPA group showed a 25% relative risk reduction in major adverse cardiovascular events (MACE) compared to placebo. The absolute risk reduction was 4.8 percentage points — a substantial effect by cardiovascular trial standards.
This was pure EPA, not combined EPA+DHA. Some researchers have argued that the mineral oil placebo used in the control arm may have slightly inflated the treatment effect by mildly raising LDL-C. However, even accounting for this critique, REDUCE-IT represents the strongest single trial evidence for omega-3 in cardiovascular disease.
VITAL (Vitamin D and Omega-3 Trial) tested 1g/day of combined EPA+DHA (Omacor/Lovaza) in a general population without established cardiovascular disease. Results were more modest: no significant reduction in the primary MACE endpoint. However, subgroup analyses showed significant benefits in patients with low fish intake at baseline, and a significant 24% reduction in cancer mortality — an unexpected finding that spawned several follow-up trials. VITAL confirmed that 1g/day is likely too low for cardiovascular protection in a general population, but suggests cancer risk reduction may require less.
Liao et al. pooled data from 26 randomized controlled trials of omega-3 supplementation for major depressive disorder. The key finding: formulations where EPA comprised >60% of the total omega-3 dose produced significant antidepressant effects (standardized mean difference = −0.55, a clinically meaningful effect). DHA-dominant or roughly equal EPA:DHA formulations did not reach significance. The effective EPA doses ranged from 1–2g/day. This was a landmark finding because it shifted the clinical recommendation from generic "fish oil" to EPA-specific supplementation for mood disorders.
The Age-Related Eye Disease Study 2 evaluated omega-3 supplementation (350mg DHA + 650mg EPA daily) alongside antioxidant nutrients for progression of age-related macular degeneration. While the omega-3 arm did not reduce AMD progression beyond the antioxidant formula alone, the trial confirmed that the retina has exceptionally high DHA requirements and that DHA status matters for photoreceptor membrane integrity. DHA-specific supplementation remains a core recommendation for AMD management in combination with the AREDS2 antioxidant formula.
This is where most fish oil buyers get it wrong. The form of omega-3 in your supplement determines how much you actually absorb.
Wild fish contain omega-3 in natural triglyceride (TG) form — the EPA and DHA are attached to a glycerol backbone as part of a triglyceride molecule, just like all other dietary fats. Your digestive system handles this efficiently: pancreatic lipase cleaves the fatty acids, they're absorbed via bile salt micelles, and the whole system works the way it evolved to work.
When fish oil is concentrated to raise EPA and DHA percentages — which is what most commercial fish oil does — the natural triglycerides are transesterified into ethyl esters (EE). This is a cheaper, faster process. Ethyl esters are not a natural dietary fat form. Your lipase cleaves them less efficiently, absorption requires more bile, and bioavailability is roughly 30–50% lower than TG form depending on the study (some studies cite up to 70% lower in a fasted state).
The best form is re-esterified triglyceride (rTG). In rTG processing, the ethyl esters are converted back to triglycerides after concentration. You get the high EPA+DHA content of a concentrated product with the bioavailability of natural fish. This process is more expensive, which is why rTG products cost more. It's worth it.
| Form | Source | Relative Bioavailability | Cost |
|---|---|---|---|
| Natural Triglyceride (TG) | Unprocessed fish oil, cod liver oil | 100% (reference) | Low–Medium |
| Ethyl Ester (EE) | Most concentrated fish oil capsules | ~50–73% (fasted); ~85–90% with a fatty meal | Low |
| Re-esterified TG (rTG) | Premium concentrated fish oil | ~124% vs natural TG (some studies) | High |
| Phospholipid (krill oil) | Krill | ~110–125% vs natural TG | Very High (low absolute dose) |
One practical note: taking ethyl ester fish oil with a high-fat meal significantly closes the bioavailability gap. If you're taking EE fish oil and can't switch, always take it with your fattiest meal of the day. But if you're buying new, choose rTG.
Omega-3 fatty acids are polyunsaturated — meaning they have multiple double bonds that are chemically unstable and prone to oxidation when exposed to heat, light, or oxygen. Oxidized fish oil doesn't just lose its benefits. Oxidized lipids (lipid peroxides, aldehydes) are directly pro-inflammatory and have been shown in animal studies to promote atherosclerosis — the exact opposite of what you're taking fish oil for.
A 2015 Norwegian study found that over 50% of commercial fish oil products exceeded recommended oxidation levels based on TOTOX scores. A 2017 New Zealand analysis found that 83% of retail fish oil products exceeded at least one oxidation measure. The problem is widespread.
The primary oxidation measure is TOTOX score (Total Oxidation), calculated as: TOTOX = 2 × PV (peroxide value) + AnV (anisidine value). The Council for Responsible Nutrition recommends TOTOX ≤26. The Global Organization for EPA and DHA Omega-3s (GOED) sets the same standard. Brands that get IFOS (International Fish Oil Standards) certification test to these thresholds and publish their results.
The smell test: Fresh fish oil in rTG or TG form should smell mildly of the sea — not pungently fishy, not like fried food, not acrid. Strong fishy smell = oxidation. If your fish oil burps taste rancid, that's your oxidation signal. Quality manufacturers will enteric coat or use antioxidants like vitamin E (mixed tocopherols) to protect the oil through shelf life.
Brands with consistently verified low TOTOX scores include Nordic Naturals, Carlson Labs, and Thorne — all of which publish third-party testing data and hold IFOS certification on most product lines.
Fish don't actually synthesize omega-3s. They accumulate EPA and DHA by eating microalgae — phytoplankton that produce these fatty acids at the base of the marine food chain. Algae oil is the primary source; fish are the intermediary.
Algae-derived omega-3 supplements offer several advantages: they're vegan, they have zero heavy metal contamination risk (no bioaccumulation in a single-celled organism), they require no fishing, and they're more environmentally sustainable. The tradeoff is that most algae oil products are DHA-dominant with limited EPA — they replicate the omega-3 profile for brain health and pregnancy but are less suited to the EPA-dominant protocols for depression or cardiovascular disease.
For vegans or those concerned about ocean contamination, algae oil is an excellent DHA source. Thorne's algae oil and Nordic Naturals Algae Omega are two well-tested options. For therapeutic EPA dosing (≥1g EPA for mood or inflammation), fish oil or EPA-specific products remain the practical choice.
The contaminant concern with fish oil is real but manageable. Polychlorinated biphenyls (PCBs), dioxins, and mercury accumulate via the food chain — the higher the trophic level, the higher the concentration. This is why large, long-lived fish (tuna, swordfish, shark) carry higher mercury loads than small, short-lived fish.
Most commercial fish oil is sourced from wild sardines, anchovies, and mackerel — small forage fish that are naturally low in heavy metals. Molecular distillation (the industry-standard purification process) removes PCBs and dioxins to below detectable levels. This is not optional — any reputable manufacturer uses it.
IFOS-certified products test for PCBs, dioxins, furans, and mercury and publish the results. If a brand doesn't publish third-party purity testing, that's a red flag regardless of how it's marketed.
Use this as a framework, not a rigid rule:
Read the label carefully. Most fish oil capsules list the total fish oil weight, not the EPA+DHA content. A "1000mg fish oil" capsule typically contains 300mg combined EPA+DHA. To get 2g of combined EPA+DHA from a standard fish oil, you'd need to take 6–7 capsules daily. Higher-concentration rTG products solve this — a 1000mg capsule of concentrated fish oil might deliver 600–750mg EPA+DHA.
Dose: 2g combined EPA+DHA daily (adjust to 3–4g for inflammatory conditions or mood support)
Form: rTG (re-esterified triglyceride) — not ethyl ester
Timing: With breakfast or your fattiest meal of the day
Certification: IFOS-certified; verify published TOTOX score
Depression / mood protocol: Choose EPA-dominant formulation (>60% EPA of combined total); minimum 1g EPA/day
Vegan: Algae oil (DHA-focused); supplement with EPA-specific algae if available
Storage: Refrigerate after opening; discard if smell becomes strongly fishy or rancid
These three products represent the best combinations of form quality, third-party testing, EPA+DHA concentration, and value. All are IFOS-certified with published oxidation data.
Nordic Naturals' flagship concentrate delivers 650mg EPA + 450mg DHA per serving in rTG form. IFOS 5-star rated. Manufactured in Norway. Lemon-flavored to mask oxidation cues — and the published TOTOX scores are consistently well below the 26-point threshold. This is the benchmark product in the category and the one most frequently cited in clinical discussions.
→ Nordic Naturals Ultimate Omega on AmazonCarlson's Elite Omega-3 delivers 800mg EPA + 600mg DHA per serving in rTG form — one of the highest concentrations available without a prescription product. IFOS certified. Carlson has been testing and publishing third-party omega-3 purity data longer than almost any other brand. Fresh lemon flavor; excellent published TOTOX performance. Strong value per gram of EPA+DHA.
→ Carlson Elite Omega-3 on AmazonFor vegans or those avoiding fish products, Nordic Naturals Algae Omega provides 195mg EPA + 390mg DHA per serving from sustainably farmed microalgae. No heavy metal concerns. Certified vegan. EPA content is lower than fish-based options, making this best for general maintenance, pregnancy DHA support, and children's formulations rather than therapeutic EPA protocols. Third-party tested.
→ Nordic Naturals Algae Omega on AmazonStackProtocol participates in the Amazon Associates program. Purchases through these links support the site at no extra cost to you.
Not all fish oil is equal. The form matters more than the brand. Buy rTG form, IFOS-certified, and dose 2–4g combined EPA+DHA daily — not 2–4 capsules of generic fish oil that may deliver only 300mg of active omega-3 per capsule. Take it with food. Refrigerate after opening. Discard if it smells rancid.
Choose EPA-dominant if your goal is mood, inflammation, or cardiovascular protection. Choose DHA-forward if your goal is brain development, pregnancy, or eye health. Use algae oil if you're vegan — just be aware that most algae products are DHA-heavy and you may need to supplement EPA separately for therapeutic protocols.
Omega-3 is one of three supplements that has sufficient evidence to recommend for almost everyone. The others are vitamin D and creatine. The barrier isn't evidence — it's buying the right form at the right dose and actually taking it.
Bhatt DL et al. (2019). Cardiovascular risk reduction with icosapentaenoic acid for hypertriglyceridemia. NEJM. REDUCE-IT trial.
Manson JE et al. (2019). Marine n-3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer. NEJM. VITAL trial.
Liao Y et al. (2019). Efficacy of omega-3 PUFAs in depression: A meta-analysis. Translational Psychiatry.
Age-Related Eye Disease Study 2 Research Group. (2013). Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration. JAMA.
Dyerberg J et al. (2010). Bioavailability of marine n-3 fatty acid formulations. Prostaglandins, Leukotrienes and Essential Fatty Acids.
Opperman M & Benade S. (2013). Analysis of omega-3 fatty acid content of South African fish oil supplements. Cardiovascular Journal of Africa.
Hilbert G et al. (2015). Oxidation of omega-3 fatty acids in commercial fish oil supplements. Preventive Nutrition and Food Science.
As an Amazon Associate, StackProtocol earns from qualifying purchases made through links on this page. This does not affect the price you pay.